The analyst predicts that with the increase in the number of AIDS patients in China, the sales of Emtricitabine/Tenofovir will also increase from 2016 to 2019. In 2019, the number of surviving HIV infections in China reached 958,000. In 2020, the number of surviving AIDS infections in China increased to 1.045 million, with an increase of 9%. The number of new infections will still show an increasing trend in the future. How to prevent new HIV infections has become the key to prevent and control the spread of AIDS. Therefore, sales in Emtricitabine/Tenofovir of the preventive HIV drugs will continue to increase. By 2020, 2 companies have launched generic versions of Truvada (Emtricitabine/Tenofovir) in China. The generic version from Chia Tai Tianqing Pharmaceutical Group Co., Ltd. is the first Chinese-made HIV combination tablet in the country. Qilu Pharmaceutical and Hisco Pharmaceutical are waiting for an Abbreviated New Drug Application (ANDA) approval for their generic version, and they will compete for the market after approval. The market competition of Emtricitabine/Tenofovir in China will become more intense. Sales prices are expected to continue to fall, and sales volume will increase accordingly. In addition, the effective alleviation of the COVID-19 epidemic during the period of 2021-2025 will also enable the sales of Emtricitabine/Tenofovir to have restorative growth.
Topics Covered:
- The impact of COVID-19 on China's Emtricitabine/Tenofovir market
- Sales value of China's Emtricitabine/Tenofovir 2016-2020
- Competitive landscape of China's Emtricitabine/Tenofovir market
- Prices of Emtricitabine/Tenofovir in China
- Prices of Emtricitabine/Tenofovir in China by regions and manufacturers
- Analysis of factors affecting the development of China's Emtricitabine/Tenofovir market
- Prospect of China's Emtricitabine/Tenofovir market from 2021 to 2025
Table of Contents
Companies Mentioned
- Gilead Sciences Inc
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Methodology
Background research defines the range of products and industries, which proposes the key points of the research. Proper classification will help clients understand the industry and products in the report.
Secondhand material research is a necessary way to push the project into fast progress. The analyst always chooses the data source carefully. Most secondhand data they quote is sourced from an authority in a specific industry or public data source from governments, industrial associations, etc. For some new or niche fields, they also "double-check" data sources and logics before they show them to clients.
Primary research is the key to solve questions, which largely influence the research outputs. The analyst may use methods like mathematics, logical reasoning, scenario thinking, to confirm key data and make the data credible.
The data model is an important analysis method. Calculating through data models with different factors weights can guarantee the outputs objective.
The analyst optimizes the following methods and steps in executing research projects and also forms many special information gathering and processing methods.
1. Analyze the life cycle of the industry to understand the development phase and space.
2. Grasp the key indexes evaluating the market to position clients in the market and formulate development plans
3. Economic, political, social and cultural factors
4. Competitors like a mirror that reflects the overall market and also market differences.
5. Inside and outside the industry, upstream and downstream of the industry chain, show inner competitions
6. Proper estimation of the future is good guidance for strategic planning.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| Published | June 2021 |
| Forecast Period | 2016 - 2025 |
| Estimated Market Value ( CNY | CNY 4.89 Million |
| Forecasted Market Value ( CNY | CNY 124.77 Million |
| Compound Annual Growth Rate | 43.3% |
| Regions Covered | China |
| No. of Companies Mentioned | 2 |
